These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 26805806

  • 1. Graveoline Analogs Exhibiting Selective Acetylcholinesterase Inhibitory Activity as Potential Lead Compounds for the Treatment of Alzheimer's Disease.
    Li Z, Mu C, Wang B, Jin J.
    Molecules; 2016 Jan 22; 21(2):132. PubMed ID: 26805806
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X, Fu H, Yang S, Wang L, Liu AL, Wu S, Du GH.
    Molecules; 2017 Jul 26; 22(8):. PubMed ID: 28933746
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of imperatorin analogs and their evaluation as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Granica S, Kiss AK, Jarończyk M, Maurin JK, Mazurek AP, Czarnocki Z.
    Arch Pharm (Weinheim); 2013 Nov 26; 346(11):775-82. PubMed ID: 24123207
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE, Park JY, No KT, Shin JH, Lee SK, Eun JS, Yang JH, Shin TY, Kim DK, Chae BS, Leem JY, Kim KH.
    Bioorg Med Chem; 2007 Oct 15; 15(20):6596-607. PubMed ID: 17681794
    [Abstract] [Full Text] [Related]

  • 5. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Wang DM, Feng B, Fu H, Liu AL, Wang L, Du GH, Wu S.
    Molecules; 2017 Jan 20; 22(1):. PubMed ID: 28117700
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R, Pourshojaei Y, Eskandari K, Mohammadi-Khanaposhtani M, Abiri A, Khodadadi A, Langarizadeh A, Sharififar F, Amirheidari B, Akbarzadeh T, Lotfian H, Foroumadi A, Asadipour A.
    Arch Pharm (Weinheim); 2019 Jul 20; 352(7):e1800352. PubMed ID: 31136018
    [Abstract] [Full Text] [Related]

  • 7. Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesis.
    Kanhed AM, Sinha A, Machhi J, Tripathi A, Parikh ZS, Pillai PP, Giridhar R, Yadav MR.
    Bioorg Chem; 2015 Aug 20; 61():7-12. PubMed ID: 26042530
    [Abstract] [Full Text] [Related]

  • 8. Ethyl nitrobenzoate: A novel scaffold for cholinesterase inhibition.
    Yeong KY, Liew WL, Murugaiyah V, Ang CW, Osman H, Tan SC.
    Bioorg Chem; 2017 Feb 20; 70():27-33. PubMed ID: 27863748
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase.
    Alipour M, Khoobi M, Nadri H, Sakhteman A, Moradi A, Ghandi M, Foroumadi A, Shafiee A.
    Arch Pharm (Weinheim); 2013 Aug 20; 346(8):577-87. PubMed ID: 23852709
    [Abstract] [Full Text] [Related]

  • 16. Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease.
    Kumar A, Pintus F, Di Petrillo A, Medda R, Caria P, Matos MJ, Viña D, Pieroni E, Delogu F, Era B, Delogu GL, Fais A.
    Sci Rep; 2018 Mar 13; 8(1):4424. PubMed ID: 29535344
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis and evaluation of novel 1,2,3-triazole-based acetylcholinesterase inhibitors with neuroprotective activity.
    Li JC, Zhang J, Rodrigues MC, Ding DJ, Longo JP, Azevedo RB, Muehlmann LA, Jiang CS.
    Bioorg Med Chem Lett; 2016 Aug 15; 26(16):3881-5. PubMed ID: 27426301
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.
    Makhaeva GF, Boltneva NP, Lushchekina SV, Rudakova EV, Serebryakova OG, Kulikova LN, Beloglazkin AA, Borisov RS, Richardson RJ.
    Bioorg Med Chem; 2018 Sep 01; 26(16):4716-4725. PubMed ID: 30104121
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis, biological evaluation and docking study of 5-oxo-4,5-dihydropyrano[3,2-c]chromene derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Khoobi M, Alipour M, Sakhteman A, Nadri H, Moradi A, Ghandi M, Emami S, Foroumadi A, Shafiee A.
    Eur J Med Chem; 2013 Oct 01; 68():260-9. PubMed ID: 23988409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.